Fig. 8

Construction and examination of the risk model in the TCGA test cohort. (A) HCC samples from the TCGA test cohort were classified as low-risk or high-risk; (B) In the TCGA test cohort, a Kaplan-Meier plot was used to compare TCGA high-risk and low-risk patients with HCC. (C–E) The risk model provides a diagnostic value for predicting survival rates at 1-year, 3-year, and 5-year follow-up in TCGA cohorts with HCC (C, D, and E); (F) A comparison of survival time and survival status of all patients with HCC in the TCGA test cohort; (G) Expression levels of TRIM36, CYP26B1, PAGE1, CDK5R2, and DCAF8L1 in HCC tissues collected from low-risk and high-risk patients in the TCGA test cohort